ERBB2 and breast cancer: Molecular subclassification of BC identified four subtypes: Lum A, Lum B, HER2 positive tumors, and TNBC with the distribution of the subtypes in our study of 19.6%, 56.2%, 18.3%, and 5.9%, respectively (Table 1).